Published in Exp Brain Res on January 01, 1997
Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient. Front Cell Neurosci (2014) 0.83
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A (1990) 16.34
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (1993) 8.29
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem (1991) 5.84
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70
Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science (1994) 5.15
Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys (1991) 4.71
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev (1995) 3.05
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65
ALS, SOD and peroxynitrite. Nature (1993) 2.64
Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron (1992) 2.54
A radical hypothesis for neurodegeneration. Trends Neurosci (1993) 2.50
A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol (1992) 2.47
Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys (1992) 2.37
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci (1994) 2.25
Selective sparing of a class of striatal neurons in Huntington's disease. Science (1985) 2.16
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci (1993) 2.16
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience (1996) 2.06
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem (1989) 1.94
Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett (1982) 1.89
Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol (1991) 1.81
Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci (1990) 1.51
Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol (1990) 1.43
Glutathione-related enzymes in brain in Parkinson's disease. Ann Neurol (1994) 1.29
Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem (1995) 1.29
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord (1994) 1.18
Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures. Brain Res (1992) 1.15
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta (1995) 1.07
Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann Neurol (1992) 1.01
Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci Lett (1992) 1.01
Mitochondrial dysfunction in movement disorders. Curr Opin Neurol (1994) 0.97
Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci U S A (1994) 0.95
Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions. Neuroreport (1992) 0.94
Nitric oxide: cellular regulation and neuronal injury. Prog Brain Res (1994) 0.92
Oxidative stress in Parkinson's disease. Neuropathol Appl Neurobiol (1995) 0.87
Reduction of striatal N-methyl-D-aspartate toxicity by inhibition of nitric oxide synthase. Biochem Pharmacol (1993) 0.85
Inhibition of nitric oxide synthase protects against hypoxic neuronal injury. Neuroreport (1992) 0.82
Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J Neurochem (1996) 0.79
Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. Neuroreport (1994) 0.76
Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists. Brain Res (1988) 0.76
Identification of NO-producing and -receptive cells in mesencephalic transplants in a rat model of Parkinson's disease: a study using NADPH-d enzyme- and NOSc/cGMP immunocytochemistry. Ann N Y Acad Sci (1994) 0.75
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci (1999) 3.06
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med (1992) 2.01
Weight loss in Huntington disease increases with higher CAG repeat number. Neurology (2008) 1.66
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat Med (1995) 1.61
High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neurol (2006) 1.53
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Functional integration of cortical grafts placed in brain infarcts of rats. Ann Neurol (1993) 1.43
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet (2001) 1.42
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci U S A (1999) 1.30
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol (1997) 1.29
A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ (2011) 1.27
Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature (1990) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience (2005) 1.22
Synaptic dysfunction in Huntington's disease: a new perspective. Cell Mol Life Sci (2005) 1.16
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain (1999) 1.14
Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol (1992) 1.13
Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res (1986) 1.11
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur J Neurosci (2001) 1.10
Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol (2001) 1.09
Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice. Neurobiol Dis (2002) 1.06
Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med (1999) 1.06
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp Brain Res (1988) 1.04
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis (2006) 1.03
The executioners sing a new song: killer caspases activate microglia. Cell Death Differ (2011) 1.02
Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke (1993) 1.00
Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur J Neurosci (2001) 1.00
Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature (1984) 0.99
Recent advances on the pathogenesis of Huntington's disease. Exp Neurol (1999) 0.98
Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience (1985) 0.97
Brain injury activates microglia that induce neural stem cell proliferation ex vivo and promote differentiation of neurosphere-derived cells into neurons and oligodendrocytes. Neuroscience (2010) 0.96
Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem (2003) 0.96
The future of cell therapies and brain repair: Parkinson's disease leads the way. Neuropathol Appl Neurobiol (2014) 0.96
Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol (1992) 0.96
Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp Brain Res (1995) 0.96
In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron (1990) 0.96
Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci U S A (1994) 0.95
Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp Brain Res (1993) 0.93
trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. J Neurochem (2000) 0.93
Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res (1994) 0.92
Phenotypic development of the human embryonic striatal primordium: a study of cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience (1996) 0.91
Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J Comp Neurol (1992) 0.91
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine. Eur J Neurosci (2001) 0.90
Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp Neurol (1999) 0.90
Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res (1985) 0.89
In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res (1986) 0.89
Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res (1988) 0.88
Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet (1989) 0.88
Working memory training decreases hippocampal neurogenesis. Neuroscience (2006) 0.88
Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res Dev Brain Res (1995) 0.88
Mutant huntingtin can paradoxically protect neurons from death. Cell Death Differ (2007) 0.87
Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res (1993) 0.86
DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience (1996) 0.86
Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res (1985) 0.86
Middle cerebral artery occlusion in the hypertensive and normotensive rat: a study of histopathology and behaviour. J Hypertens (1988) 0.86
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease. Exp Neurol (2002) 0.86
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int J Pharm (2006) 0.85
Quinolinic acid-induced inflammation in the striatum does not impair the survival of neural allografts in the rat. Eur J Neurosci (1998) 0.85
Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience (1997) 0.85
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats. Exp Neurol (2009) 0.85
Intrastriatal grafting of dopamine-containing neuronal cell suspensions: effects of mixing with target or non-target cells. Brain Res (1986) 0.84
Survival of fetal neocortical grafts implanted in brain infarcts of adult rats: the influence of postlesion time and age of donor tissue. Exp Neurol (1994) 0.84
Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann N Y Acad Sci (1987) 0.83
Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp Neurol (1989) 0.83
Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death. Brain Res Bull (2001) 0.83
Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons. Brain Res (2000) 0.83
Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. J Neurochem (2001) 0.82
Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1. Neuroscience (2010) 0.82
The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting. Brain Res (1986) 0.82
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease. Neurobiol Dis (2008) 0.81
Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease. Neurobiol Dis (1997) 0.81
Grafts of fetal locus coeruleus neurons in rat amygdala-piriform cortex suppress seizure development in hippocampal kindling. Exp Neurol (1989) 0.81
Degeneration and graft-induced restoration of dopamine innervation in the weaver mouse neostriatum: a quantitative radioautographic study of [3H]dopamine uptake. Exp Brain Res (1989) 0.81
Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Neuroscience (1993) 0.81
Neurodegeneration and glutamate induced oxidative stress. Prog Brain Res (1998) 0.81
Survival of expanded dopaminergic precursors is critical for clinical trials. Nat Neurosci (1998) 0.81
Neural grafting in a rat model of Huntington's disease: striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry and receptor autoradiography. Neuroscience (1987) 0.81
Grafted noradrenergic neurons suppress seizure development in kindling-induced epilepsy. Proc Natl Acad Sci U S A (1987) 0.81
Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats. Neuroscience (1995) 0.81
Addition of lateral ganglionic eminence to rat mesencephalic grafts affects fiber outgrowth but does not enhance function. Cell Transplant (1997) 0.80
Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats. Exp Brain Res (1986) 0.80
Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice. Exp Brain Res (1989) 0.80
Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor Neurol Neurosci (1991) 0.80
Platelet-derived growth factor exerts trophic effects on rat striatal DARPP-32-containing neurons in culture. Exp Brain Res (1994) 0.80
Intracerebral grafting of fetal noradrenergic locus coeruleus neurons: evidence for seizure suppression in the kindling model of epilepsy. Prog Brain Res (1988) 0.80
Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected? Cell Transplant (1994) 0.80
Increased survival of embryonic nigral neurons when grafted to hypothermic rats. Neuroreport (2000) 0.80
Expression of platelet-derived growth factor in and around intrastriatal embryonic mesencephalic grafts. Cell Transplant (1994) 0.80
Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: immune responses and functional effects. Cell Transplant (2000) 0.79
Rat intrastriatal neural allografts challenged with skin allografts at different time points. Exp Neurol (1997) 0.79
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease. Exp Neurol (2011) 0.79
Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience (1987) 0.79
Caspase inhibition increases embryonic striatal graft survival. Exp Neurol (2000) 0.79
Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J Neurochem (1996) 0.79
Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: ingrowth of afferent fibers from the host brain. Exp Neurol (1992) 0.78
Neural transplantation in Parkinson's disease: the Swedish experience. Prog Brain Res (1990) 0.78
Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons. Brain Res (1998) 0.78
FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons. Exp Neurol (2000) 0.78